Document is current
Any future updates will be listed below
-
Authors
Reitz, Katherine M.
Althouse, Andrew D.
Forman, Daniel E.
Zuckerbraun, Brian S.
Vodovotz, Yoram
Zamora, Ruben
Raffai, Robert L.
Hall, Daniel E.
Tzeng, Edith http://orcid.org/0000-0002-5762-6798
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05132439 at ClinicalTrials.govDocuments that mention this clinical trial
MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol
https://doi.org/10.1186/s12872-023-03047-8
-
Funding
Funding for this research was provided by:
VA Pittsburgh Healthcare System (CX002150)
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 5 January 2023
First Online: 21 January 2023
Declarations
:
: The MOBILE IC Trial was reviewed by the FDA and was identified as exempt from Investigational New Drug review (IND145416). The VAPHS Investigational Review Board approved the procedures specified by the MOBILE IC study protocol which includes written informed consent for each participant completed by the investigators in combination with study personnel (1622906; Supplement). Any future protocol modifications will be reviewed by the institutional review board, discussed with the DMC, and any other relevant parties prior to implementation.
: Not applicable.
: No author reports any disclosures, conflict of interest or relevant financial interests related to the content of the manuscript. The opinions expressed here are those of the authors and do not necessarily reflect the position of the Department of Veterans Affairs or the US government.
